STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Medical Care Technologies Inc. (OTC Pink:MDCE) Closes Reg A - Dilution Ends, Growth Phase Begins

Rhea-AI Impact
(High)
Rhea-AI Sentiment
(Neutral)
Tags

Medical Care Technologies (OTC Pink: MDCE) announced its Regulation A Tier 1 offering will formally conclude on December 6, 2025, ending the dilution period tied to that offering and stopping further share issuance under Reg A.

The company said proceeds from the offering, together with an intentionally lean cost structure, have positioned MDCE to focus on product launches, revenue expansion, and AI innovation throughout 2026. Planned initiatives include a debut consumer-facing nutrition intelligence and recipe generation mobile platform and continued growth of subsidiaries Infinite Auctions and Real Game Used.

Loading...
Loading translation...

Positive

  • Reg A offering set to conclude on December 6, 2025
  • No additional shares to be issued through the Reg A offering
  • Proceeds earmarked to fund AI mobile apps and product launches in 2026
  • Capital supports growth of subsidiaries Infinite Auctions and Real Game Used

Negative

  • None.

MESA, ARIZONA / ACCESS Newswire / December 5, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE) is pleased to announce that its Regulation A Tier 1 Offering will formally conclude on December 6, 2025, marking a major milestone in the Company's corporate transition and strengthening its capital structure.

With the completion of the offering, no additional shares will be issued through the Reg A, concluding the dilution period that supported early-stage development and strategic subsidiary growth. Coupled with the Company's intentionally lean operational model, the proceeds from the offering have positioned MDCE with the financial flexibility needed to focus aggressively on product launches, revenue expansion, and AI innovation throughout 2026.

"We built a foundation to scale - and now we're ready to accelerate," said Marshall Perkins III, CEO of Medical Care Technologies Inc. "By completing our Reg A and maintaining a lower-overhead model, we are now in the driver's seat to push forward the development of our AI-powered health and nutrition technologies at full speed."

The Company highlighted that the capital raised will directly support the rollout of MDCE's forthcoming catalog of consumer-focused AI mobile applications - including its debut nutrition intelligence and recipe generation platform - as well as continued growth of its established subsidiaries Infinite Auctions and Real Game Used.

"We want our investors to know that this moment marks the transition into our growth phase," added Perkins. "We are incredibly excited for what's next."


About Medical Care Technologies Inc.

Medical Care Technologies Inc. (www.medicalcaretechnologies.com, www.mdcestock.com) is an emerging health-technology company creating AI-driven consumer applications across wellness, nutrition, and preventive screening. Fueled by proven subsidiary operations and a lean innovation strategy, the Company is focused on scalable AI products designed to improve everyday health and lifestyle decisions.


Safe Harbor Statement

This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially due to various risks and uncertainties. The Company assumes no obligation to update forward-looking statements.

Contact:

Investor Relations
Medical Care Technologies Inc.
info@infiniteauctions.com
Website: www.mdcestock.com

SOURCE: Medical Care Technologies Inc. (OTC Pink:MDCE)



View the original press release on ACCESS Newswire

FAQ

What does Medical Care Technologies (MDCE) announcing Reg A closure on December 6, 2025 mean for shareholders?

The company says the Reg A will end dilution because no more shares will be issued under that offering after December 6, 2025.

How will MDCE use the funds raised from the Regulation A offering for 2026 initiatives?

MDCE states proceeds will support product launches, revenue expansion, and AI innovation, including a nutrition intelligence mobile platform.

Will Medical Care Technologies (MDCE) issue more shares under the Reg A after December 6, 2025?

No; the company announced that no additional shares will be issued through the Reg A offering once it concludes.

Which MDCE subsidiaries are named for continued growth after the Reg A completion?

The company specifically named Infinite Auctions and Real Game Used as subsidiaries targeted for continued growth.

Does MDCE link the Reg A completion to changes in its operating model or costs?

MDCE described maintaining a lower-overhead operational model and said the capital from the offering supports its shift into a growth phase.
Medical Care Technologies Inc

OTC:MDCE

MDCE Rankings

MDCE Latest News

MDCE Stock Data

1.11M
Internet Retail
Consumer Cyclical
Link
United States
Mesa